Skip to main content

Perumpail, Brandon Joseph, MD

Perumpail, Brandon Joseph, MD

Perumpail, Brandon Joseph, MD

Perumpail, Brandon Joseph, MD, is a fellow with the Division of Gastroenterology, Hepatology and Nutrition at the Children's Hospital of Philadelphia.


215-590-3630

267-425-2739

About Perumpail, Brandon Joseph, MD

Titles

Fellow

Leadership and Memberships

American Academy of Pediatrics (AAP) 
American Association for the Study of Liver Diseases (AASLD)

Education & training

Undergraduate Degree

BS in Biology - Drexel University Philadelphia, PA

Medical Degree

MD - Drexel University College of Medicine, Philadelphia, PA

 

 


 

Team affiliations

View fewer all team affiliations View all all team affiliations

Publications

Abstracts (includes Posters and Scientific Presentations)

2023

Kim, D., Perumpail, B.J., Wijarnpreecha, K., Manikat, R., Cholankeril, G., & Ahmed, A. . Trends in etiology-based hospitalisation for cirrhosis before and during the COVID-19 pandemic in the United States. Alimentary Pharmacology & Therapeutics. (2023, Jul); 58(2): 218-228. Cited in PubMed; PMID: 37189243. Pub Status: Published.

Perumpail, B.J., & Salehi, V.. (2023, May 19). A (Potentially) Fatal Attraction: Incidentally Found Multiple Magnetic Foreign Body Ingestion Necessitating Surgical Intervention Poster presented at: St. Christopher's Hospital for Children Research Day; Philadelphia, PA.

Perumpail, B.J., Hogan, G., & Feinstein, L.. (2023, May 19). Food Insecurity Screening in an Urban Pediatric Gastroenterology Clinic Poster presented at: St. Christopher's Hospital for Children Research Day; Philadelphia, PA.

2022

Kim, D., Perumpail, B.J., Alshuwaykh, O., Dennis, B.B., Cholankeril, G., & Ahmed, A.. Changing trends in aetiology-based hospitalizations with end-stage liver disease in the United States from 2016 to 2019. Liver International. (2022, Nov); 42(11): 2390-2395. Cited in PubMed; PMID: 35906461. Pub Status: Published.

2021

Dennis, B.B., Sallam, S., Perumpail, B.J., Shah, N.D., Cholankeril, G., & Ahmed, A.. Management of Cardiometabolic Complications in Patients With Nonalcoholic Fatty Liver Disease: A Review of the Literature With Recommendations. Journal of Clinical Gastroenterology. (2021, Oct); 55(9): 747-756. Cited in PubMed; PMID: 34469404. Pub Status: Published.

2019

Perumpail, B. J., Li, A. A., John, N., Sallam, S., Shah, N. D., Kwong, W., Cholankeril, G., Kim, D., & Ahmed, A. The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD. Diseases. (2019, Feb); 7(1): 27. Cited in PubMed; PMID: 30823570. Pub Status: Published.

Kim, D., Li, A. A., Perumpail, B. J., Gadiparthi, C., Kim, W., Cholankeril, G., Glenn, J. S., Harrison, S.A., Younossi, Z. M., & Ahmed, A. Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States. Hepatology. (2019, Mar); 69(3): 1064-1074. Cited in PubMed; PMID: 30014489. Pub Status: Published.

Iqbal, U., Perumpail, B. J., Akhtar, D., Kim, D., & Ahmed, A. The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease. Medicines. (2019, Mar); 6(1): 41. Cited in PubMed; PMID: 30889791. Pub Status: Published.

2018

Yoo, E. R., Sallam, S., Perumpail, B. J., Iqbal, U., Shah, N. D., Kwong, W., Cholankeril, G., Kim, D., & Ahmed, A. When to Initiate Weight Loss Medications in the NAFLD Population. Diseases. (2018, Sep); 6(4): 91. Cited in PubMed; PMID: 30274326. Pub Status: Published.

Perumpail, B. J., Li, A. A., John, N., Sallam, S., Shah, N. D., Kwong, W., Cholankeril, G., Kim, D., & Ahmed, A. The Role of Vitamin E in the Treatment of NAFLD. Diseases. (2018, Sep); 6(4): 86. Cited in PubMed; PMID: 30249972. Pub Status: Published.

Perumpail, B. J., Li, A. A., Iqbal, U., Sallam, S., Shah, N. D., Kwong, W., Cholankeril, G., Kim, D., & Ahmed, A. Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD. Diseases. (2018, Sep); 6(3): 80. Cited in PubMed; PMID: 30201879. Pub Status: Published.

Iqbal, U., Perumpail, B. J., John, N., Sallam, S., Shah, N. D., Kwong, W., Cholankeril, G., Kim, D., & Ahmed, A. Judicious Use of Lipid Lowering Agents in the Management of NAFLD. Diseases. (2018, Sep); 6(4): 87. Cited in PubMed; PMID: 30249980. Pub Status: Published.

Gadiparthi, C., Cholankeril, G., Perumpail, B. J., Yoo, E. R., Satapathy, S. K., Nair, S., & Ahmed, A. Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates. World Journal of Gastroenterology. (2018, Jan); 24(3): 315-322. Cited in PubMed; PMID: 29391754. Pub Status: Published.

Dibba, P., Li, A. A., Perumpail, B. J., John, N., Sallam, S., Shah, N. D., Kwong, W., Cholankeril, G., Kim, D., & Ahmed, A. Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD. Diseases. (2018, Sep); 6(3): 83. Cited in PubMed; PMID: 30235807. Pub Status: Published.

Cholankeril, R., Patel, V., Perumpail, B. J., Yoo, E. R., Iqbal, U., Sallam, S., Shah, N. D., Kwong, W., Kim, D., & Ahmed, A. Anti-Diabetic Medications for the Pharmacologic Management of NAFLD. Diseases. (2018, Oct); 6(4): 93. Cited in PubMed; PMID: 30282916. Pub Status: Published.

2017

Yang, C. H., Perumpail, B. J., Yoo, E. R., Ahmed, A., & Kerner, J. A., Jr. Nutritional Needs and Support for Children with Chronic Liver Disease. Nutrients. (2017, Oct); 9(10): 1127. Cited in PubMed; PMID: 29035331. Pub Status: Published.

Siddique, O., Yoo, E. R., Perumpail, R. B., Perumpail, B. J., Liu, A., Cholankeril, G., & Ahmed, A. The importance of a multidisciplinary approach to hepatocellular carcinoma. Journal of Multidisciplinary Healthcare. (2017, Mar); 10(n.a.): 95-100. Cited in PubMed; PMID: 28360525. Pub Status: Published.

Perumpail, B. J., Li, A. A., Cholankeril, G., Kumari, R., & Ahmed, A. Optimizing the Nutritional Support of Adult Patients in the Setting of Cirrhosis. Nutrients. (2017, Oct); 9(10): 1114. Cited in PubMed; PMID: 29027963. Pub Status: Published.

Perumpail, B. J., Khan, M. A., Yoo, E. R., Cholankeril, G., Kim, D., & Ahmed, A. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. World Journal of Gastroenterology. (2017, Dec); 23(47): 8263-8276. Cited in PubMed; PMID: 29307986. Pub Status: Published.

Perumpail, B. J., Cholankeril, R., Yoo, E. R., Kim, D., & Ahmed, A. An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease. Diseases. (2017, Oct); 5(4): 23. Cited in PubMed; PMID: 29065499. Pub Status: Published.

Cholankeril, G., Joseph-Talreja, M., Perumpail, B. J., Liu, A., Yoo, E. R., Ahmed, A., & Goel, A. Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents. Journal of Clinical and Translational Hepatology. (2017, Dec); 5(4): 363-367. Cited in PubMed; PMID: 29226102. Pub Status: Published.

Books

2019

Kim, D., Siddique, O., Perumpail, B. J., & Ahmed, A. (2019). Clinical Epidemiology of NAFLD. In Wong, R., & Gish, R. (Ed.), Clinical Epidemiology of Chronic Liver Diseases (pp. 211-227). Cham: Springer International Publishing.

Jump back to top